Alexion – Buy Signal

NASDAQ listed Alexion Pharmaceuticals is now under Algo Engine buy conditions.

May 6, 2020-Alexion Pharmaceuticals announced first quarter 2020 revenues of 1.bn, (27% increase on the same time last year).

You're not a member!  Trial today!

On a GAAP basis, diluted EPS in the quarter was $2.50, a 4 percent decrease versus the prior year.

Non-GAAP diluted EPS for the first quarter of 2020 was $3.22, a 35 percent increase versus the first quarter of 2019.

Investor Signals Pty Ltd ABN 44 143 555 453 is a Corporate Authorised Representative CAR No. 439411 of Advisor Plus Pty Ltd AFSL 474520
© 2020 Investor Signals